Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis
Trial details
- Registry ID
- NCT03737110
- Drugs studied
- Rilonacept
TrialRedline tracks 1 clinical trial sponsored by Kiniksa Pharmaceuticals (UK), Ltd.: 1 Phase 3.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent PericarditisNCT03737110 | Rilonacept | Completed | 2020-05-29Actual |
Names as written in the registry records.